Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1967-5-26
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0148-916X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4290017-Adrenocorticotropic Hormone,
pubmed-meshheading:4290017-Antitubercular Agents,
pubmed-meshheading:4290017-Clinical Trials as Topic,
pubmed-meshheading:4290017-Erythema Nodosum,
pubmed-meshheading:4290017-Humans,
pubmed-meshheading:4290017-Leprosy,
pubmed-meshheading:4290017-Phenazines,
pubmed-meshheading:4290017-Sulfones
|
pubmed:articleTitle |
The treatment of erythema nodosum leprosum with B.663. A controlled study.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|